摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,4,5,5-Tetramethyl-1,2,3-trioxolane | 14582-05-9

中文名称
——
中文别名
——
英文名称
4,4,5,5-Tetramethyl-1,2,3-trioxolane
英文别名
4,4,5,5-tetramethyltrioxolane
4,4,5,5-Tetramethyl-1,2,3-trioxolane化学式
CAS
14582-05-9
化学式
C6H12O3
mdl
——
分子量
132.159
InChiKey
VYBWZPRMSKKTKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    79.1±23.0 °C(Predicted)
  • 密度:
    0.953±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    27.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDINONE ET DE PYRIMIDINONE COMME INHIBITEURS DU FACTEUR XIA
    申请人:ONO PHARMACEUTICAL CO
    公开号:WO2013093484A1
    公开(公告)日:2013-06-27
    The present invention provides compounds of the general formula (I), their salts and N- oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.
    本发明提供了一般式(I)的化合物,它们的盐和N-氧化物,以及它们的溶剂合物和前药(其中字符如描述中所定义)。一般式(I)的化合物是因子XIa的抑制剂,因此它们在预防和/或治疗血栓栓塞疾病方面是有用的。
  • Investigation of the Thermal and Photochemical Reactions of Ozone with 2,3-Dimethyl-2-butene
    作者:Bridgett E. Coleman、Bruce S. Ault
    DOI:10.1021/jp108457w
    日期:2010.12.9
    The matrix isolation technique, combined with infrared spectroscopy and twin jet codeposition, has been used to characterize intermediates formed during the ozonolysis of 2,3-dimethyl-2-butene (DMB). Absorptions of early intermediates in the twin jet experiments grew up to 200% upon annealing to 35 K. A number of these absorptions have been assigned to the elusive Criegee intermediate (CI) and secondary
    基质分离技术与红外光谱法和双喷射共沉积技术相结合,已被用于表征2,3-二甲基-2-丁烯(DMB)臭氧分解过程中形成的中间体。在双射流实验中,退火至35 K时,早期中间体的吸收量增长了200%。其中许多此类吸收物已分配给DMB难以捉摸的Criegee中间体(CI)和次要臭氧化物(SOZ),以前未观察到瞬态物质对于这个系统。与早期研究一致,还观察到主要的臭氧化物(POZ)。在λ≥220至≥580 nm的辐射下探索了这些产物谱带的光解构的波长依赖性。合并的射流(流动反应器)实验生成了DMB的“晚期”稳定氧化产物。d = 0至-11 cm),然后到达冷室进行光谱检测。18 O和加扰的16,18 O同位素标记实验以及B3LYP / 6-311 ++ G(d,2p)水平的理论密度泛函计算进一步支持了DMB臭氧分解过程中形成的中间体的鉴定。
  • Matrix effects in the low-temperature ozonation of ethylene, tetramethylethylene and 1-hexene
    作者:U Samuni、Y Haas、R Fajgar、J Pola
    DOI:10.1016/s0022-2860(98)00459-1
    日期:1998.8
    deposited at low temperature, and having an amorphous structure. The reaction was found to start at 26 K, the temperature at which the matrix undergoes a phase transition. In contrast, only tetramethylethylene (TME) was found to react in an argon matrix, the other two compounds remaining inactive towards ozone up to the softening temperature of argon (∼40 K). These results are interpreted as indicating
    摘要 在氩气和 CO2 基质中在低温 (12–80 K) 下研究了标题化合物的臭氧化作用。发现所有三种都与低温沉积的 CO2 基质中的臭氧反应,并具有无定形结构。发现反应开始于 26 K,即基质发生相变的温度。相比之下,只有四甲基乙烯 (TME) 被发现在氩气基质中反应,其他两种化合物在氩气软化温度 (~40 K) 之前对臭氧保持惰性。这些结果被解释为表明一旦两种反应物自由移动到所需的配置,烯烃和臭氧之间的反应就会在低温下引发。这个想法得到了 TME 反应的分子动力学模拟的支持。TME初级臭氧化物的红外光谱,
  • IMIDAZOPYRIDINES SYK INHIBITORS
    申请人:Gilead Connecticut, Inc.
    公开号:EP2545052B1
    公开(公告)日:2014-11-12
  • US9040718B2
    申请人:——
    公开号:US9040718B2
    公开(公告)日:2015-05-26
查看更多

同类化合物

青蒿氧烷 甲基3-甲基-1,2,4-三氧杂环戊烷-3-羧酸酯 烯丙基苯臭氧化物 5-乙酰基-3,5-二甲基-1,2,4-三氧杂环戊烷-3-甲腈 3-苯基-1,2,4-三氧杂螺[5.4]癸烷 3-甲基-3-苯基-1,2,4-三氧杂螺[5.4]癸烷 3,5-二苯基-1,2,4-三氧杂环戊烷 3,3-二丁基-1,2,4-三氧杂螺[5.4]癸烷 1-异丙基-4-甲基-2,3,7-三氧杂双环[2.2.1]庚烷 1-(5-甲氧基-3-甲基-1,2,4-三四氢呋喃-3-基)乙酮 1-(5,5-二甲基-1,2,4-三四氢呋喃-3-基)乙酮 1-(3,5,5-三甲基-1,2,4-三四氢呋喃-3-基)乙酮 1,2,4-三噁戊环,3-(1-氯乙烯基)- cis-1,4-Dimethyl-2,3,17-trioxabicyclo<12.2.1>heptadecane trans-1,4-Dimethyl-2,3,17-trioxabicyclo<12.2.1>heptadecane adamantane-2-spiro-3'-8'-hydroxy-8'-methyl-1',2',4'-trioxaspiro[4.5]decane adamantane-2-spiro-3'-8'-hydroxy-1',2',4'-trioxaspiro[4.5]decane (3-methyl-1,2,4-trioxolan-3-yl)hexanal (3-methyl-5-phenyl-5-trifluoromethyl-1,2,4-trioxolan-3-yl)pentanal trioxolane 7 3-tert-butyl-3-methyl-5-phenyl-5-trifluoromethyl-1,2,4-trioxolane 3-Cyano-5-cyclohexyl-3-isobutyl-1,2,4-trioxolane 5'-Cyano-5'-isobutylspiro (trans-5-cyano-5-phenyl-1,2,4-trioxolan-3-yl)-3-cyclopentanecarbaldehyde 5'-Cyano-5'-phenylspiro 3-Cyano-3,5-diphenyl-1,2,4-trioxolane 3-Cyano-3-phenyl-5-tert-butyl-1,2,4-trioxolane 3-tert-Butyl-3-methyl-1,2,4-trioxaspiro[5.4]decane (trans-5-cyano-3,5-dimethyl-1,2,4-trioxolan-3-yl)hexanal (trans-5-cyano-5-methyl-1,2,4-trioxolan-3-yl)hexanal 3,5-dimethyl-5-(3-oxopropyl)-1,2,4-trioxolane-3-carbonitrile (trans-5-cyano-5-methyl-1,2,4-trioxolan-3-yl)pentanal 3-Cyano-3-methyl-5-phenyl-1,2,4-trioxolane 3-Cyano-5-cyclohexyl-3-methyl-1,2,4-trioxolane (E)-3-methyl-5-[7-oxohept-5-enyl]-1,2,4-trioxolane-3-carbonitrile (Z)-3-methyl-5-[5-oxopent-1-enyl]-1,2,4-trioxolane-3-carbonitrile (E)-3-methyl-5-[6-oxohex-4-enyl]-1,2,4-trioxolane-3-carbonitrile 3-methyl-5-[(E)-5-oxopent-3-enyl]-1,2,4-trioxolane-3-carbonitrile (Z)-3-methyl-5-[4-methyl-7-oxohept-3-enyl]-1,2,4-trioxolane-3-carbonitrile 3-(Chloromethyl)-3-methoxy-1,2,4-trioxolane cis-3,5-bis-(chloromethyl)-3,5-dimethoxy-1,2,4-trioxolane trans-3,5-bis-(chloromethyl)-3,5-dimethoxy-1,2,4-trioxolane cis-adamantane-2-spiro-3'-8'-[[(4'-formyl-1'-piperazinyl)carbonyl]methyl]-1',2',4'-trioxaspiro[4.5]decane adamantane-2-spiro-3’-8’-hydroxymethyl-1’,2’,4’-trioxaspiro[4,5]decane 3-(Chloromethyl)-3-fluoro-1,2,4-trioxolane trans-3,5-Bis(chloromethyl)-3-fluoro-1,2,4-trioxolane methyl spiro3,7>decane-2,3'-<1,2,4>trioxolane>-5'-carboxylate 3-Cyano-3-phenyl-1,2,4-trioxolane 3-ethyl-1,24-trioxolane dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1''-cyclohexane]-3''-ol